SynthesisFrontiers in oncology2026
Effectiveness of exergaming interventions for adults with cancer: a systematic review.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Exergaming, which integrates physical exercise with interactive digital games, has gained attention as a supportive approach in cancer rehabilitation. However, uncertainty remains regarding its effects across different phases of cancer care and its feasibility in clinical and home-based settings. This systematic review synthesized evidence on the feasibility, safety, and effects of exergaming interventions among adults with cancer, with particular attention to interventions delivered during active treatment and after treatment completion. Methods: PubMed, Web of Science, the Cochrane Library, Scopus, Embase, CINAHL, and SPORTDiscus were searched from inception to April 2025. Randomized and nonrandomized intervention studies evaluating exergaming among adults with cancer were included. Outcomes were synthesized narratively across physical, psychological, symptom-related, quality-of-life, biological or physiological, and feasibility domains. Results: Twenty-five publications representing 19 distinct study cohorts met the inclusion criteria. Interventions varied substantially in platform, setting, duration, and training dose, most commonly lasting 4-16 weeks with 2-5 sessions per week. Reported recruitment rates ranged from 11.8% to 85.7%, adherence from 62% to 100%, and attrition from 0% to 47.4%. No serious intervention-related adverse events were reported among studies that provided safety data, although adverse-event reporting was incomplete. Favorable findings were reported for physical activity, mobility, balance, upper-extremity function, fatigue, and selected psychological and quality-of-life outcomes. In contrast, findings for muscle strength, pain, body composition, and biological or physiological markers were inconsistent. Conclusions: Exergaming appears to be a feasible and acceptable adjunct to cancer rehabilitation, with potential benefits for selected physical, symptom-related, and psychosocial outcomes. However, the evidence remains preliminary, and exergaming should be considered an adjunct rather than a replacement for conventional exercise or physiotherapy. Adequately powered randomized trials using standardized intervention protocols, consistent outcome reporting, longer follow-up, and more diverse cancer populations are needed. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024530181, identifier CRD42024530181.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.